186 related articles for article (PubMed ID: 22764183)
1. Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS.
Mulder BA; van Veldhuisen DJ; Crijns HJ; Böhm M; Cohen-Solal A; Babalis D; Roughton M; Flather MD; Coats AJ; Van Gelder IC
Eur J Heart Fail; 2012 Oct; 14(10):1171-8. PubMed ID: 22764183
[TBL] [Abstract][Full Text] [Related]
2. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
[TBL] [Abstract][Full Text] [Related]
3. Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study.
von Haehling S; van Veldhuisen DJ; Roughton M; Babalis D; de Boer RA; Coats AJ; Manzano L; Flather M; Anker SD
Eur J Heart Fail; 2011 Jun; 13(6):656-63. PubMed ID: 21613429
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
Flather MD; Shibata MC; Coats AJ; Van Veldhuisen DJ; Parkhomenko A; Borbola J; Cohen-Solal A; Dumitrascu D; Ferrari R; Lechat P; Soler-Soler J; Tavazzi L; Spinarova L; Toman J; Böhm M; Anker SD; Thompson SG; Poole-Wilson PA;
Eur Heart J; 2005 Feb; 26(3):215-25. PubMed ID: 15642700
[TBL] [Abstract][Full Text] [Related]
5. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
de Boer RA; Doehner W; van der Horst IC; Anker SD; Babalis D; Roughton M; Coats AJ; Flather MD; van Veldhuisen DJ;
Am J Cardiol; 2010 Jul; 106(1):78-86.e1. PubMed ID: 20609652
[TBL] [Abstract][Full Text] [Related]
6. Influence of systolic blood pressure on clinical outcomes in elderly heart failure patients treated with nebivolol: data from the SENIORS trial.
Montero-Perez-Barquero M; Flather M; Roughton M; Coats A; Böhm M; Van Veldhuisen DJ; Babalis D; Solal AC; Manzano L
Eur J Heart Fail; 2014 Sep; 16(9):1009-15. PubMed ID: 25044535
[TBL] [Abstract][Full Text] [Related]
7. Effects of nebivolol on biomarkers in elderly patients with heart failure.
Taneja AK; Gaze D; Coats AJ; Dumitrascu D; Spinarova L; Collinson P; Roughton M; Flather MD;
Int J Cardiol; 2014 Aug; 175(2):253-60. PubMed ID: 24877590
[TBL] [Abstract][Full Text] [Related]
8. Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.
Dobre D; van Veldhuisen DJ; Mordenti G; Vintila M; Haaijer-Ruskamp FM; Coats AJ; Poole-Wilson PA; Flather MD;
Am Heart J; 2007 Jul; 154(1):109-15. PubMed ID: 17584562
[TBL] [Abstract][Full Text] [Related]
9. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
[TBL] [Abstract][Full Text] [Related]
11. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
Conraads VM; Metra M; Kamp O; De Keulenaer GW; Pieske B; Zamorano J; Vardas PE; Böhm M; Dei Cas L
Eur J Heart Fail; 2012 Feb; 14(2):219-25. PubMed ID: 22147202
[TBL] [Abstract][Full Text] [Related]
12. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.
Rienstra M; Damman K; Mulder BA; Van Gelder IC; McMurray JJ; Van Veldhuisen DJ
JACC Heart Fail; 2013 Feb; 1(1):21-8. PubMed ID: 24621795
[TBL] [Abstract][Full Text] [Related]
14. Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy.
Ghio S; Magrini G; Serio A; Klersy C; Fucili A; Ronaszèki A; Karpati P; Mordenti G; Capriati A; Poole-Wilson PA; Tavazzi L;
Eur Heart J; 2006 Mar; 27(5):562-8. PubMed ID: 16443607
[TBL] [Abstract][Full Text] [Related]
15. Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study.
Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Groenveld HF; Van den Berg MP; Van Gelder IC;
Eur J Heart Fail; 2013 Nov; 15(11):1311-8. PubMed ID: 23759284
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol for heart failure in the elderly.
Tavazzi L
Expert Rev Cardiovasc Ther; 2007 May; 5(3):423-33. PubMed ID: 17489667
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
[TBL] [Abstract][Full Text] [Related]
18. Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure.
Del Sindaco D; Tinti MD; Monzo L; Pulignano G
Clin Interv Aging; 2010 Dec; 5():381-93. PubMed ID: 21152240
[TBL] [Abstract][Full Text] [Related]
19. Is heart rate important for patients with heart failure in atrial fibrillation?
Cullington D; Goode KM; Zhang J; Cleland JG; Clark AL
JACC Heart Fail; 2014 Jun; 2(3):213-20. PubMed ID: 24952686
[TBL] [Abstract][Full Text] [Related]
20. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
